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Epigenetic Changes in Mitochondrial Superoxide
Dismutase in the Retina and the Development of
Diabetic Retinopathy
Qing Zhong and Renu A. Kowluru
OBJECTIVE—To investigate the role of epigenetic regulation of
the manganese superoxide dismutase gene (sod2) in the devel-
opment of diabetic retinopathy and the metabolic memory phe-
nomenon associated with its continued progression after
hyperglycemia is terminated.
RESEARCH DESIGN AND METHODS—Streptozotocin-
induced diabetic rats were maintained in poor glycemic control
(PC, GHb ;12%) or in good glycemic control (GC, GHb ;7.0%)
for 4 months, or were allowed to maintain PC for 2 months,
followed by GC for 2 additional months (PC-Rev). For experimen-
tal galactosemia, a group of normal rats were fed a 30% galactose
diet for 4 months or for 2 months, followed by a normal diet for 2
additional months. Trimethyl histone H4 lysine 20 (H4K20me3),
acetyl histone H3 lysine 9 (H3K9), and nuclear transcriptional
factor NF-kB p65 and p50 at the retinal sod2 promoter and en-
hancer were examined by chromatin immunoprecipitation.
RESULTS—Hyperglycemia (diabetes or galactosemia) increased
H4K20me3, acetyl H3K9, and NF-kB p65 at the promoter and
enhancer of retinal sod2, upregulated protein and gene expres-
sion of SUV420h2, and increased the interactions of acetyl H3K9
and NF-kB p65 to H4K20me3. Reversal of hyperglycemia failed to
prevent increases in H4K20me3, acetyl H3K9, and NF-kB p65 at
sod2, and sod2 and SUV420h2 continued to be abnormal. Silenc-
ing SUV420h2 by its small interfering RNA in retinal endothelial
cells prevented a glucose-induced increase in H4K20me3 at the
sod2 enhancer and a decrease in sod2 transcripts.
CONCLUSIONS—Increased H4K20me3 at sod2 contributes to
its downregulation and is important in the development of dia-
betic retinopathy and in the metabolic memory phenomenon.
Targeting epigenetic changes may serve as potential therapeutic
targets to retard the development and progression of diabetic
retinopathy. Diabetes 60:1304–1313, 2011
R
etinopathy is a debilitating vascular complica-
tion of diabetes. Despite extensive research, the
molecular mechanism of its development re-
mains elusive. Superoxide radicals are elevated
in the retinal mitochondria and their scavenging enzyme,
manganese superoxide dismutase (MnSOD), is compro-
mised (1–3). This decrease in MnSOD activity is observed
as early as 2 months after induction of hyperglycemia
in rats (1), and the enzyme remains compromised at du-
ration when capillary cell apoptosis or pathology charac-
teristic of diabetic retinopathy are observed in the retinal
vasculature (4–7). Prevention of MnSOD inhibition by the
administration of antioxidants or overexpression of sod2
prevents the development of diabetic retinopathy in
rodents (6,8,9), suggesting it has a major role in the de-
velopment of diabetic retinopathy. However, how diabetes
regulates retinal MnSOD remains to be explored.
The nuclear gene, sod2, encodes MnSOD, and the tran-
scription of sod2 is driven by regulators binding on its
promoter and enhancer regions (10,11). Redox-sensitive
nuclear transcriptional factor, NF-kB, which acts as pro-
apoptotic factor in the pathogenesis of diabetic retinopathy,
binds to the promoter and enhancer of sod2. The NF-kB
p65/p50 heterodimer increases sod2, and p50/p50 sup-
presses it (12–14). Gene expression is also regulated by the
chromatin structure that is modulated by histone mod-
iﬁcations (15). Acetylation of histone H3 lysine 9 (H3K9)
is considered to activate gene transcription, and tri-
methylation of histone H4 lysine 20 (H4K20) to repress (15).
These modiﬁcations are initiated by speciﬁce n z y m e s ,
and SUV420h2/KMT5C (SUV420h2) is considered one of
the prime enzymes for the trimethylation of H4K20 (16).
High glucose exposure of bovine aortic endothelial cells
altered methylation of H3K4 and H3K9 on the p65 pro-
moter of NF-kB (17). However, regulation of retinal sod2
in diabetes by histone modiﬁcations and NF-kBr e m a i n s
unclear.
Good glycemic control, if started in the initial stage of
diabetes, prevents the development of retinopathy, but if
reinstituted after a period of poor control, fails to halt its
development, suggesting a metabolic memory phenome-
non. Patients in the conventional treatment regimen during
the Diabetes Complications and Control Trial had a higher
incidence of complications several years after switching to
intensive therapy than the patients in intensive control
(18). Studies in rats have demonstrated that the retina
continues to experience oxidative stress, MnSOD remains
compromised, and NF-kB is activated for at least 6 months
after reinstitution of good glycemic control that has fol-
lowed 6 months of poor control (7,19–21). The accumu-
lation of damaged mitochondrial DNA continues in the
retina and its capillary cells (22,23). Histone modiﬁcations
are linked with persistent activation of NF-kB after tran-
sient hyperglycemia in aortic endothelial cells, and this
activation is prevented by reducing mitochondrial super-
oxide (24). Our recent study has suggested the role of
retinal H3 global acetylation in the metabolic memory
phenomenon (25). However, how the epigenetic regulation
of sod2 contributes to the metabolic memory phenomenon
remains to be explored.
In the current study, we used two animal models of di-
abetic retinopathy to investigate the mechanism by which
histone modiﬁcations regulate retinal sod2 in the de-
velopment of retinopathy and in the metabolic memory
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ORIGINAL ARTICLEphenomenon associated with its resistance to arrest after
hyperglycemia is terminated. Because the retina is a com-
plex tissue with multiple cell types, key ﬁndings are also
conﬁrmed in isolated retinal endothelial cells, the cells that
are the target of the histopathology that is characteristic of
diabetic retinopathy.
RESEARCH DESIGN AND METHODS
Animals. Wistar rats (male, 200 g) were randomly assigned to normal, diabetic,
or experimentally galactosemic groups. Diabetes was induced with strepto-
zotocin (55 mg/kg body wt), and 3 to 4 days after induction of diabetes, the rats
were divided into three groups: group 1 rats were in poor glycemic control
(glycated hemoglobin [GHb] .12%) for 4 months (PC group), group 2 rats
were in poor control for 2 months, followed by good control for 2 additional
months (PC-Rev group), and group 3 rats were in good control (GC group,
GHb ;7.0%). The PC rats received 1 to 2 units of insulin (Humulin; Eli Lilly,
Indianapolis, IN) four to ﬁve times a week, and the GC rats received insulin
twice daily for a total of 7 to 8 units. Experimental galactosemia was induced
in normal rats (Galac group) by feeding 30% galactose supplemented diet. The
Galac group rats received the galactose diet for the entire 4 months of the
study, and the Galac-Rev group received galactose diet for the ﬁrst 2 months
and a normal diet for 2 additional months. The control group comprised
normal age-matched rats.
Blood was obtained by weekly tail vein puncture to measure glucose by
Freestyle Glucometer (Bayer, Tarrytown, NY), and GHb (every 2 months) using
a kit from Helena Laboratories (Beaumont, TX). These procedures conformed
to the Association for Research in Vision and Ophthalmology Resolution on
Treatment of Animals in Research and are routinely used in our laboratory
(7,12,19–22). At the end of the experiment, rats were killed by carbon dioxide
asphyxiation, and the retina was removed immediately. About 50% of the
retina was crosslinked with 1% paraformaldehyde, and the remaining was
stored in liquid nitrogen.
Retinal endothelial cells and transfection. Endothelial cells prepared
from bovine retina were cultured in medium consisting of 15% FBS (heat in-
activated), 5% replacement serum (Nu-serum; BD Bioscience, San Jose, CA),
heparin (50 mg/mL), endothelial growth supplement (25 mg/mL), and antibiotic/
antimycotic in Dulbecco’sm o d i ﬁed Eagle’s medium (9,23). Conﬂuent cells from
passages four to ﬁve were incubated in high glucose (20 mmol/L) for 4 days,
followed by normal glucose (5 mmol/L) for 4 additional days (20-5 group). The
controls included cells incubated in normal or high glucose for 8 days of the
experiment, and 20 mmol/L mannitol served as an osmotic control. At the end of
the incubation, the cells were processed for chromatin immunoprecipitation, as
described below.
Endothelial cells from the passages three to ﬁve were transfected with small
interfering RNA (siRNA) of SUV420h2 or NF-kB p65 using transfection
reagents from Santa Cruz Biotechnology (Santa Cruz, CA) as routinely per-
formed in our laboratory (26). Brieﬂy, after incubation of siRNA transfection
complex for 45 min at room temperature, the cells were incubated with the
transfection complex for 8 h at 37°C. Parallel incubations were done using
nontargeting scrambled RNA. For sod2 overexpression, the cells were in-
cubated with 3 mgo fsod2 plasmid and effectene transfection reagent (Qiagen,
Valencia, CA), as described by us (23). At the end of the transfection, the cells
were washed with PBS and incubated in 5 mmol/L or 20 mmol/L glucose for 4
days. The transfection efﬁciency was veriﬁed by semiquantitative PCR using
control primers from Santa Cruz Biotechnology.
Chromatin immunoprecipitation. Rat retina or isolated endothelial cells
were crosslinked with 1% paraformaldehyde for 15 min. The ﬁxed sample was
resuspended in lysis buffer containing 1% SDS, 10 mmol/L EDTA, 50 mmol/L
Tris-HCl, pH 8.1 (ChIP Assay Kit, Millipore, Temecula, CA), and protease in-
hibitor cocktail (Sigma-Aldrich, St. Louis, MO), and sonicated four to six times
for 10 s each. Supernatant was diluted in ChIP dilution buffer containing 0.01%
SDS, 1.1% Triton X-100, 1.2 mmol/L EDTA, 16.7 mmol/L Tris-HCl, pH 8.1, and
167 mmol/L NaCl, and precleared with protein A agarose/salmon sperm DNA
for 30 min.
After a small aliquot of protein-DNA complex (15–20 mg) was collected for
starting chromatin input, the protein-DNA complex was immunoprecipitated
with the antibody against NF-kB p65 or p50, acetyl H3K9, H4K20me3 or rabbit
normal IgG (Abcam, Cambridge, MA), or anti-general transcription factor IIB
(TFIIB, Millipore Corporation, Temecula, CA). The immunoprecipitate col-
lected with protein A agarose/salmon sperm DNA was washed sequentially
with low-salt buffer, high-salt buffer, and LiCl buffer, according to the vendor’s
protocol. After the immunoprecipitate was washed twice with Tris-EDTA
buffer, the sample was used for Western blotting or was extracted twice with
1% SDS containing 0.1 mol/L NaHCO3.
Elutes and input were heated at 65°C for 4 h to reverse the formaldehyde
crosslinking and digested with protease K at 45°C for 1 h. DNA fragments were
recovered by phenol-chloroform-isoamyl alcohol extraction and ethanol pre-
cipitation, and resuspended in 20 mL water for PCR. Gene expression of sod2
promoter and enhancer were quantiﬁed by SYBR green-based real-time
quantitative PCR (q-PCR). Promoter of b-actin occupied by TFIIB and the off-
target region of sod2 were used as ChIP positive and negative controls, re-
spectively, and normal rabbit IgG was used as the negative antibody control
and DNA from input as the internal control. Each ChIP measurement was
made in ﬁve to six rats per group or four to ﬁve cell preparations.
Gene expression.Geneexpressionswere conﬁrmedbyq-PCRusing 7500 Real
Time PCR System (Applied Biosystem, Foster City, CA) with SYBR green
Master Mix (Applied Biosystem, Branchburg, NJ) or TaqMan primers.
Ampliﬁcation of the sod2 promoter and enhancer was performed in 1 mLo f
ChIP-puriﬁed DNA using the primers provided in Table 1. PCR was performed
by denaturing at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C
for 15 s, annealing and extension at 60°C for 60 s, and this was followed by 95°C





Forward CCAGGAATGGAAAAGGAGTG 2529 to 2510
Reverse CTTGTAACAGAGCGGCACAC 2282 to 2301
Rat sod2 enhancer
Forward CTGGGAAACGGGTTGAGTAA 1672 to 1691
Reverse TACCACAGCCTTCCCAAATC 1872 to 1853
Rat sod2 off-target
Forward CGCGGTGTCGGTGGCATGA 175 to 193
Reverse CCCCTGCATCGAAACAGACTTCCG 488 to 465
Bovine sod2 promoter
Forward GAGCCGTACCATCTCTTTCG 2345 to 2326
Reverse CTTCCAACTCCGGGGAAAT 2135 to 2153
Bovine sod2 enhancer
Forward AGCCTGTGTATGCAACCATCT 4905 to 4925
Reverse CCCCAAATTATGTGTCCCAG 5118 to 5099
Bovine b-actin promoter
Forward CAGGGCGGCCAACGCCAAAA 2251 to 2232
Reverse CGAGAGGCCTGTGCTAGCGG +41 to +22
For TaqMan primers, gene bank accession numbers for rat SUV420h2, sod2, and b-actin are NM_001107475.1, NM_017051.2, NM_031144.2,
and for bovine SUV420h2, sod2, and 18S are XM_598002, NM_201527.2, and X03205.1, respectively.
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sample using the DDCt method. Relative fold-changes were calculated by
setting the mean fraction of normal rats as 1. For quantifying the gene
expressions of SUV420h2 and sod2, TaqMan primers were used. Each sample
was measured in triplicate. Fold-change in mRNA abundance was calculated
with the DDCt method as routinely used by us (22,23).
Western blotting. Chromatin pellets or retinal homogenate were boiled for
5 to 10 min in SDS-PAGE sample buffer, and separated on a 4–20% gradient
polyacrylamide gel. The proteins blotted onto membranes were blocked and
incubated with the primary antibody against acetyl H3K9, or mono-, di-, or
trimethyl H4K20 (H4K20me1, me2, and me3, respectively), or SUV420h2
(Abcam). After enhancing the target proteins with enhanced chem-
iluminescence reagent (Thermo Scientiﬁc, Rockford, IL), they were de-
termined by autoradiography. The membranes were reprobed with normal
rabbit IgG or b-actin (Sigma-Aldrich, St. Louis, MO) or histone H4 (Cell Sig-
naling, Danvers, MA). The band intensity was quantiﬁed using Un-Scan-It Gel
digitizing software (Silk Scientiﬁc, Orem, UT), and protein expression was
calculated relative to normal rabbit IgG in ChIP or b-actin or histone H4 in the
same samples.
For immunoprecipitation, 100–200 mg of retinal protein was incubated
overnight with 1 mg antibody against NF-kB p65 or H4K20me3. The antibody-
protein complex was collected with Protein A/G Plus-agarose (Santa Cruz
Biotechnology) and separated on a 4–20% gradient gel. The membranes were
probed for H4K20me3 or acetyl H3K9, and NF-kB p65 or H4K20me3 served as
loading controls for their respective membranes. The precipitate obtained
from normal rabbit IgG (Abcam) served as the negative control.
Statistical analysis. Results are presented as mean 6 SD, and analyzed using
the nonparametric Kruskal-Wallis test, followed by the Mann-Whitney test for
multiple group comparison. Similar conclusions were achieved by using
ANOVA with Fisher or Tukey tests. P , 0.05 is considered as signiﬁcant.
RESULTS
Severity of hyperglycemia in rats. The body weights of
the rats in the PC group were signiﬁcantly lower, and their
GHb values were more than twofold higher compared with
the age-matched normal control rats (317 6 32 vs. 439 6
68 g and 12.3 6 2.0 vs. 5.9 6 0.9%, respectively). The rats in
the GC group had body weight and GHb values (445 6 14 g
and 7.0 6 0.4%, respectively) that were similar to the
normal rats (P . 0.05). In PC-Rev group, the body weights
and GHb levels before initiation of good glycemic control
were not different from the rats in the PC group (272 6
30 g and 11.8 6 2.0%, respectively). However, after initia-
tion of good control, the values became similar to those in
the normal group (395 6 35 g and 6.9 6 0.3%). The GHb
value in the Galac group was slightly higher than in the
normal group (;8%), but was signiﬁcantly lower than in
the PC group (P , 0.05). The average body weights of the
Galac group were ;400 g, and became similar to the
normal rats after termination of the galactose diet (447 6
21 g, GHb 6.1 6 0.3%).
Effect of hyperglycemia on epigenetic modiﬁcation of
sod2. Diabetes inhibited the activity of retinal MnSOD (1)
and also decreased its gene transcripts by 60% (Fig. 1).
H4K20me3 and acetyl H3K9 were elevated by 6–11-fold at
both the promoter and the enhancer of sod2 (Fig. 2A and B).
Because H4K20me3 was increased at sod2, the protein
levels of H4K20me1, -me2, and -me3 were also quantiﬁed.
As shown in Fig. 2C, methylation of H4K20 was increased
in diabetes, and the increase in H4K20me2 and -me3 was
signiﬁcantly higher than that in H4K20me1. Gene and
protein expressions of SUV420h2, the enzyme with dy-
namic functions for di- and trimethylation (16,27), were
signiﬁcantly elevated (Fig. 2D and E). In the same retina
samples, although NF-kB p65 was elevated by more than
10-fold at both the promoter and enhancer of sod2 (Fig. 3A),
p50 was elevated only at its enhancer (Fig. 3B).
To verify the speciﬁcity of the proteins binding to the
promoter and enhancer of sod2, the same ChIP DNA from
normal rats was ampliﬁed using an off-target primer (am-
pliﬁed from +175 to +488 of sod2) by semiquantitative PCR
(Fig. 3C) and conﬁrmed by q-PCR (Fig. 3D). As shown in
Fig. 3C and D, despite substantially enriched H4K20me3,
acetyl H3K9, and NF-kB p65 at the promoter of sod2, off-
target region existing in input and genomic DNA was not
occupied by them and nonspeciﬁc precipitate by normal
IgG was almost undetectable. H4K20me3 and acetyl H3K9
proteins, co-immunoprecipitated with p65 in chromatin,
were signiﬁcantly increased (Fig. 4A).
To verify interaction of H4K20me3 or acetyl H3K9 with
NF-kB p65, retinal homogenate was immunoprecipitated
with NF-kB p65 or H4K20me3 antibodies. Figure 4B shows
that diabetes signiﬁcantly increased the interaction of
H4K20me3 or acetyl H3K9 with NF-kB p65. Owing to the
increased expression of retinal NF-kB p65 in the PC and
PC-Rev groups compared with normal (consistent with our
previous results showing the activation of retinal NF-kB
p65 in diabetes [12]), despite much higher interactions
depicted in the Western blots, the accompanying histo-
gram shows about a twofold increase in the ratio. How-
ever, retinal protein precipitated with rabbit IgG (negative
control) yielded negligible expressions of H4K20me3 or
acetyl H3K9 (Fig. 4C). In addition, as shown in Fig. 4D,i n
the same animals, diabetes also increased the interaction
of H4K20me3 and acetyl H3K9.
As with diabetes, gene expression of retinal sod2 were
signiﬁcantly reduced in the retina obtained from experi-
mentally galactosemic rats, and H4K20me3 and acetylated
H3K9 at both the promoter and enhancer of sod2 were
elevated (Fig. 2). This was accompanied by concomitant
increases of p65 and p50 at the enhancer of sod2, and only
p65 at the promoter of sod2 (P , 0.05 compared with
normal, Fig. 3).
Reversal of hyperglycemia and retinal sod2. Reinsti-
tution of good glycemic control for 2 months after 2
months of poor glycemic control (PC-Rev) failed to pro-
vide any beneﬁt to retinal sod2 (Fig. 1). It had no signiﬁ-
cant effect on retinal H4K20me3 and acetyl H3K9 at the
promoter and enhancer of sod2,a n dSUV420h2 expression
remained elevated (Fig. 2). The diabetes-induced increase
FIG. 1. Gene expression of sod2 in rat retina. RNA was isolated from
the retina using TRIzol reagent, and 1 mg RNA was converted to single-
stranded cDNA and quantiﬁed spectrophotometerically. Gene expres-
sion was measured in a 90-ng cDNA template using the ABI-7500
sequence detection system. Each sample was analyzed in triplicate, and
the data were normalized to b-actin expression in each sample. Fold-
change relative to age-matched normal rats was calculated using the
DDCt method. Results are from ﬁve or more rats in each group and are
represented as mean 6 SD. *P < 0.05 compared with normal. Nor,
normal.
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1306 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgFIG. 2. Retinal H4K20me3 and acetyl H3K9 at sod2, methylation of H4K20, and the expression of SUV420h2: the levels of acetyl H3K9 (A) and
H4K20me3 (B)a tt h esod2 promoter and enhancer were determined using the ChIP technique. Retinal chromatins were immunoprecipitated with
H4K20me3 or acetyl H3K9 antibody, and the sod2 promoter and enhancer region were ampliﬁed. The q-PCR value in each immunoprecipitate was
normalized to the Ct value from the input sample using the DDCt method. C: The protein expression of methylated H4K20 was detected by Western
blot technique using antibodies speciﬁc for mono-, di-, and trimethyl H4K20 using histone H4 as the loading control. D: Gene expression of
SUV420h2 was detected by q-PCR and analyzed by the DDCt method. The housekeeping gene was b-actin. Fold-changes were calculated by setting
the mean fraction of normal rats as 1. E: Protein expression of SUV420h2 was quantiﬁed by Western blot, and b-actin was used as a loading protein.
Values are represented as mean 6 SD of ﬁve to six rats in each group. *P < 0.05 compared with normal, and #P < 0.05 compared with PC. Nor,
normal.
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H4K20me3 and acetyl H3K9 proteins co-immunoprecipi-
tated with p65 in chromatin, and also in retinal homoge-
nate, remained signiﬁcantly elevated (P . 0.05 compared
with PC, Figs. 3 and 4). The levels of H4K20me1, -me2, and
-me3, and the expression of SUV420h2 remained elevated
(Fig. 2C–E). In concert, termination of experimental ga-
lactosemia (Galac-Rev) also failed to prevent elevations in
H4K20me3, acetyl H3K9, and p65 at the promoter and
enhancer of sod2 (Figs. 2 and 3).
Effect of continuous good glycemic control on epigenetic
modiﬁcation of retinal sod2. In contrast, when good
glycemic control was instituted immediately after induction
of diabetes in rats (GC group), values for retinal H4K20me3,
acetyl H3K9, and NF-kB p50 were signiﬁcantly different
from those obtained from the rats in PC or Galac groups.
Although p65 at the enhancer and promoter of sod2 was
slightly higher than observed in normal rats, the values
remained signiﬁcantly different from those obtained from
rats in the PC or PC-Rev groups (P , 0.05, Figs. 2 and 3).
The levels of methylated H4K20me2 and -me3, and SUV420h2
were not different from those obtained from normal rats
(Fig. 2C–E). Similarly, the values for H4K20me3 and acetyl
H3K9 proteins, co-immunoprecipitated with NF-kB p65 in
chromatin, were also lower than those observed in the PC
group (Fig. 4A).
FIG. 3. NF-kB p65 and NF-kB p50 in retinal sod2, and the speciﬁcity of the ChIP assay. The levels of retinal NF-kB p65 (A) and NF-kB p50 (B)a t
the sod2 promoter and enhancer were determined by ChIP. Fold enrichment of NF-kB p65 or p50 was compared with the values obtained from the
age-matched normal rats, which were set as 1. The speciﬁcity of the ChIP assay was veriﬁed by using an off-target primer by semiquantitative PCR
(C), and conﬁrmed by SYBER green-based real-time q-PCR (D). Immunoprecipitated DNA from normal retina was ampliﬁed using a primer speciﬁc
to an off-target region (+175 to +488) or to the promoter (2529 to 2282) region on sod2. The total genomic DNA obtained from the retina of
normal rats served as the positive DNA control. Each measurement was made in the retina obtained from ﬁve to seven rats in each group. K20me3
and AcK9, ChIP with H4K20me3 and acetyl H3K9, respectively; p65 and p50, ChIP with NF-kB p65 and p50, respectively; IgG, ChIP with normal
IgG; input, sample without ChIP; and pos control, positive control of genomic DNA. *P < 0.05 compared with normal and #P < 0.05 compared
with PC. ac, acetyl; Nor, normal.
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dothelial cells. High glucose (20 mmol/L) exposure of
retinal endothelial cells signiﬁcantly decreased the gene
expression of sod2 (P , 0.05, Fig. 5A), increased the gene
expression (Fig. 5B) and protein levels (Fig. 5C)o f
SUV420h2, and elevated H4K20me3 and acetyl H3K9 at the
promoter and enhancer of sod2 compared with the values
obtained from the cells incubated in normal glucose (Fig.
6A and B). These changes were not due to increased os-
molarity experienced by the cells in a high glucose me-
dium because the addition of 20 mmol/L mannitol instead
of 20 mmol/L glucose failed to produce any effect on
SUV420h2 gene expression and the enrichment of
H4K20me3 and acetyl H3K9 at sod2 (Figs. 5B,6 A and B).
Figure 6B and C shows that glucose exposure increased
acetyl H3K9 at the sod2 promoter, but the negative anti-
body control, IgG, produced almost negligible PCR prod-
ucts for the sod2 promoter, and the yield of ChIP IgG was
less than 2% of the product from ChIP with the acetyl H3K9
antibody. In addition, the ampliﬁcation of TFIIB (positive
control) at the b-actin promoter was similar in low and high
glucose conditions (Fig. 6C). The increased SUV420h2 gene
expression and the enrichment of H4K20me3 and acetyl
H3K9 at sod2 persisted even when 4 days of high glucose
was followed by 4 days of normal glucose exposure (20-5
group).
Because hyperglycemia increases oxidative stress, and
oxidative stress can result in epigenetic modiﬁcations, we
investigated the effect of sod2 overexpression. Figure 6A
shows that overexpression of sod2 successfully blocked
the increase of H4K20me3 at the sod2 promoter and en-
hancer. To further evaluate the effects of H4K20me3 and
NF-kB p65 on the expression of sod2, SUV420h2 or NF-kB
p65 were inhibited by their respective siRNAs. Figure 5B
and C shows that high glucose increased the gene and
protein expressions of SUV420h2, and this was successfully
prevented by siRNA-SUV420h2. Transfection with siRNA-
SUV420h2 also prevented an increase in H4K20me3 at
the sod2 enhancer and ameliorated a decrease in sod2
mRNA (Figs. 5 and 7). In addition, transfection of cells with
FIG. 4. The interactions of H4K20me3 and acetyl H3K9 with NF-kB p65 in the retina. A: The crosslinked retina was immunoprecipitated with NF-kB
p65 antibody, and the pull-down proteins in the immunoprecipitated chromatin were separated by Western blots using acetyl H3K9 and H4K20me3
antibodies. IgG was used as a loading control. The histogram (upper right) represents the intensity of each band adjusted to IgG in the same
sample. B: The interaction of NF-kB p65 with acetyl H3K9 or H4K20me3 was detected by immunoprecipitation. Rat retinal homogenate was
immunoprecipitated with NF-kB p65 antibody. Acetyl H3K9 or H4K20me3 in the precipitate was detected by Western blot. For loading efﬁciency,
the membranes were reprobed with NF-kB p65. The histograms represent the ratio of NF-kB p65/acetyl H3K9 or NF-kB p65/H4K20me3 adjusted to
p65 in each lane. C: Expressions of H4K20me3 or acetyl H3K9 in retinal protein precipitated with rabbit IgG (negative control for IP). D: For
H4K20me3 and acetyl H3K9 interactions, rat retinal homogenate was immunoprecipitated with H4K20me3 antibody, and the immunoprecipitate
was detected for acetyl H3K9 by Western blot. The values represent mean 6 SD obtained from four to ﬁve rats in each group. *P < 0.05 compared
with normal. Ac, acetyl; IP, immunoprecipitation; Nor, normal.
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p65 (Fig. 5D), further downregulated sod2 gene expression
(Fig. 5A).
DISCUSSION
The mitochondrial superoxide scavenging enzyme, MnSOD,
has an important role in protecting mitochondria from
oxidative damage. Overexpression of sod2 in diabetes
protects retinal mitochondrial DNA damage (23) and pre-
vents the development of retinopathy (3). The enzyme
activity continues to be compromised after reinstitution of
normal glycemic control in diabetic rats, suggesting it is
important in the metabolic memory phenomenon (7). This
study provides novel data showing diabetes-induced epige-
netic regulation of retinal sod2 and increased H4K20me3,
acetyl H3K9, and NF-kB p65 at its promoter/enhancer. In-
creased acetyl H3K9 and NF-kB p65 at the promoter/
enhancer of sod2 interacts with H4K20me3, suggesting a
loss of their activation function. Furthermore, reinstitution of
good control for 2 months after 2 months of hyperglycemia
has no beneﬁcial effect on increased methylation of H4K20
and acetylation of H3K9 and p65 at the promoter/enhancer
of sod2, suggesting the role of epigenetic modiﬁcations of
sod2 in the metabolic memory phenomenon associated
with the progression of diabetic retinopathy.
Histone modiﬁcations regulate gene expression, acetyl
H3K9 is considered to open up the chromatin (15), and
H4K20me3, a modiﬁcation with more general function in
chromatin management, compacts it and inhibits genes by
blocking the access of other transcription regulators to the
genes (28,29). In cancer cells, decreased acetyl H3K9 at
the promoter and enhancer of sod2 is associated with
decreased sod2 (30). In diabetes, despite decreased ac-
tivity of retinal MnSOD (7) and reduced transcripts, we
show that acetyl H3K9 and H4K20me3 are both increased
at the promoter and enhancer of sod2. In support, multiple
histone modiﬁcations can act concurrently to specify dis-
tinct chromatin structure, and modiﬁcations for activation
and repression may bind to the same gene simultaneously,
suggesting a bivalent domain. The coexistence of H3K4me3
(activator) and H3K27me3 (repressor), in addition to
downregulating genes can also activate them, and the same
lysine residue can be methylated to different degrees with
different functional consequences (31). Furthermore, we
cannot rule out the possibility that increased acetyl H3K9,
despite decreased sod2 transcript, could be due to an in-
teraction of H4K20me3 with acetyl H3K9 that abolishes the
activation function of acetyl H3K9.
The transcription-initiation site of sod2 is preceded by
a promoter with the enhancer elements located in the
second intron containing multiple potential regulatory
elements, including several SP1 sites, two NF-kB sites, and
an antioxidant-response element (32). Homodimer and
heterodimer units of NF-kB bind to DNA binding sites with
different afﬁnities within the target genes (14). NF-kBp 6 5 /
p50 binds to the enhancer and is important for cytokine-
induced sod2, and also, the binding of NF-kB p65/p50 to
the sod2 promoter is associated with its activation (30). In
contrast, p50/p50 represses sod2 by competing with p65/
p50 to the enhancer of sod2. Sp1 at the promoter and NF-
kB at the enhancer are integrated by a connection protein,
nucleophosmin, which binds to an 11-G single-strand loop
structure in the sod2 promoter (13,14,33), suggesting
strong interactions among various regulators of sod2. NF-
kB acts as a proapoptotic factor, and the expressions of
the p65 and p50 subunits are elevated in the retina in di-
abetes (12,34,35). We show that hyperglycemia increases
p65 at both promoter and enhancer, and p50 only at the
enhancer of sod2, and that genetic manipulation of p65
(siRNA) in retinal endothelial cells further decreases sod2
transcripts, supporting the role of activation of p65 at
sod2.
In addition, our results show that the p65 subunit of NF-
kB also interacts with H4K20me3, raising the possibility
that this interaction could contribute to the decreased
MnSOD activity in diabetes and that the binding of
H4K20me3 in sod2 may facilitate the recruitment of p50 to
its enhancer, decreasing the transcription. In support,
epigenetic modiﬁcations are postulated in altering gene
expression patterns associated with various diseases, in-
cluding diabetes (17,36–38).
Reinstitution of normal glycemic control for 2 months
after 2 months of hyperglycemia failed to normalize the
increased H4K20me3, p50, p65, and acetyl H3K9 at sod2,
and sod2 gene expression continued to be subnormal. The
persistent epigenetic regulation of retinal sod2 in the
FIG. 5. Gene expression of sod2, SUV420h2,a n dNF-kBp 6 5in retinal
endothelial cells. Gene expressions of sod2 (A)a n dSUV420h2 (B)
and protein expression of SUV420h2 (C) were evaluated in retinal
endothelial cells. D:T h ee f ﬁciency of NF-kBp 6 5 –siRNA on p65 gene
expression was measured by semiquantitative PCR. 5 and 20, cells
incubated in 5 mmol/L glucose or 20 mmol/L glucose; +siSU, +si-p65, or
SC, cells transfected with siRNA-SUV420h2 or siRNA–NF-kBp 6 5 ,o r
scrambled RNA, respectively, followed by incubation in 20 mmol/L
glucose for 4 days; and Mann, cells incubated in 20 mmol/L mannitol
instead of 20 mmol/L glucose. The values represent mean 6 SD
obtained from four to ﬁve different experiments, and the Western
blot (C) is representative of three different experiments. *P < 0.05
compared with the values obtained from the cells incubated in 5 mmol/L
glucose.
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consistent with the results showing persistent epigenetic
regulation of NF-kB in aortic cells (17,24). Here we show
that hyperglycemia increases SUV420h2 and methylation
of H4K20, and reversal of hyperglycemia fails to normalize
it. This could be due to regulation of histone modiﬁcation
by increased oxidative stress experienced by the retina in
diabetes, and once these modiﬁcations are formed, they
are inherited by the next cell cycle independent of the
actual glycemia (17,24,36–38). In support, our recent study
demonstrated a signiﬁcant role of histone acetylation in
the development of diabetic retinopathy and in the meta-
bolic memory phenomenon (25), and others have shown
that short-term hyperglycemia, followed by normal glu-
cose, have sustained an increase in H3K4me1 and a de-
crease in H3K9me3 at the promoter of p65 (24,36–38). The
possibility that the increased NF-kBp 6 5a tsod2 promoter
might be due to increased levels of p65 in hyperglycemic
milieu cannot be ruled out.
Experimentally, galactosemic rats do not experience
insulin deﬁciency or lipid/protein dysmetabolism but
present retinal histopathology similar to that observed in
diabetic rats (39). Similar epigenetic modiﬁcations in ga-
lactosemic animals strongly imply that hyperglycemic in-
sult is sufﬁcient to initiate epigenetic modiﬁcations of
retinal sod2 and that the process continues even after the
insult is halted.
Good glycemic control, if initiated soon after the in-
duction of diabetes, protected epigenetic changes in reti-
nal sod2. This is consistent with our previous results that
show that if the rats are maintained in good glycemic
control immediately after the induction of diabetes, the
retina escapes from increased oxidative stress and nitro-
tyrosine accumulation (7,19) and imply that the epigenetic
modiﬁcations observed in PC-Rev group during good gly-
cemic control are not inﬂuenced by high insulin adminis-
tered to maintain such glycemic control. This further
strengthens the importance of early and sustained good
glycemic control for diabetic patients.
The retina is a complex tissue with multiple layers and
cell types, and capillary cells are the major targets of the
FIG. 6. H4K20me3 and acetyl H3K9 at sod2, and evaluation of ChIP controls in retinal endothelial cells. A and B: H4K20me3 and acetyl H3K9 at the
sod2 promoter and enhancer were measured by ChIP assay with SYBR green-based real-time q-PCR. Rabbit IgG served as a negative antibody
control (indicated as ^). C: ChIP controls were veriﬁed by PCR. Crosslinked cells were immunoprecipitated with acetyl H3K9 or TFIIB antibody or
normal rabbit IgG. The sod2 promoter occupied by acetyl H3K9 and the b-actin promoter occupied by TFIIB were ampliﬁed in puriﬁed ChIP-DNA.
For the ChIP assay, the positive and negative controls were b-actin promoter occupied by TFIIB and the sod2 promoter occupied by IgG, re-
spectively. The internal control included the input. 5 and 20, cells incubated in 5 mmol/L glucose or 20 mmol/L glucose; +Mn, cells transfected with
sod2 plasmid, followed incubation in 20 mmol/L glucose for 4 days; and Mann, cells incubated in 20 mmol/L mannitol instead of 20 mmol/L glucose.
*P < 0.05 compared with the values obtained from the cells incubated in 5 mmol/L glucose. ac, acetyl.
FIG. 7. Effect of siRNA-SUV420h2 on H4K20me3 at sod2 enhancer.
The effect of siRNA-SUV420h2 on the enrichment of H4K20me3 at the
sod2 enhancer was determined by chromatin immunoprecipitating the
cells with H4K20me3 antibody. The sod2 enhancer was measured by
q-PCR. 5 and 20, cells incubated in 5 mmol/L glucose or 20 mmol/L
glucose for 4 days, respectively; +si-SU, +SC, cells transfected with
siRNA-SUV420h2 or scrambled RNA, respectively, followed by in-
cubation in 20 mmol/L glucose for 4 days. The values are represented as
mean 6 SD obtained from four to ﬁve different experiments. *P < 0.05
compared with the values obtained from the cells incubated in 5 mmol/L
glucose.
Q. ZHONG AND R.A. KOWLURU
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1311histopathology characteristic of diabetic retinopathy (40).
Results from our laboratory and others have shown that
retinal capillary cells incubated in high glucose show
similar abnormalities as those observed in the retina in
diabetes, and these cells present similar metabolic mem-
ory phenomenon as observed in the retina from diabetic
rodents (9,12,21,23,41–46). The active p65 subunit of NF-
kB is linked with persisting epigenetic changes in aortic
endothelial cells, and these changes are maintained even
hyperglycemia is removed (17). We show that genetic
manipulation of SUV420h2 prevents a glucose-induced
increase in H4K20me3 at the sod2 enhancer and a de-
crease in sod2 transcript, and overexpression of sod2
prevents an increase in H4K20me3 at sod2. This suggests
that epigenetic regulations of sod2 and SUV420h2 are un-
der the control of superoxide radicals. Failure of these
modiﬁcations to reverse after termination of hyperglyce-
mia further conﬁrms the role of sod2 epigenetic mod-
iﬁcations in the development of diabetic retinopathy and
the metabolic memory phenomenon.
The retina and its capillary cells experience mitochondrial
dysfunction in diabetes, and the pathogenic mechanisms
that are postulated in the development of complications
h a v eas i n g l eu n i f y i n gp r o c e s s —superoxide production from
the mitochondria (47). In rodent models, compromised
MnSOD activity and mitochondrial dysfunction precede the
development of diabetic retinopathy (1,3,8,48), and the mi-
tochondria remain dysfunctional when the histopathology is
seen in the retinal vasculature (3,4,7). Overexpression of
sod2 protects mitochondrial DNA from being damaged and
the retinal vasculature from the pathology (6,8,9,23), sug-
gesting a major role of MnSOD in the development of di-
abetic retinopathy. Thus, the signiﬁcance of epigenetic
regulation of sod2, observed in the current study in the
retina and in its capillary cells, further supports its con-
tributions in the development and progression of diabetic
retinopathy.
Histone modiﬁcations inﬂuence the overall chromatin
structure and result in functional consequences in cellular
processes, and methylation of H4K20 has been implicated
in DNA damage, chromatin maintenance, and transcrip-
tional repression. Although H4K20me1 is associated with
cell cycle regulation, H4K20me3 is associated with cancers
and aging (49,50). Our data demonstrate that diabetes
increases total retinal H4K20 methylation, and increases in
H4K20me2 and H4K20me3 are signiﬁcantly greater com-
pared with H4K20me1. Reversal of hyperglycemia fails
to provide any beneﬁt. Furthermore, we show that,
SUV420h2, an enzyme important for di- and trimethylation,
is increased, and that inhibition of SUV420h2 prevents
H4K20me3 at the sod2 enhancer and ameliorates a de-
crease in sod2 gene expression. However, others have
shown glucose-induced monomethylation of H3K4 by Set7
in aortic endothelial cells is associated with the tran-
scription activation and regulation of NF-kB and is im-
portant in the sustained increase in the NF-kB p65 gene
(17,24,37). Our data showing a sustained increase of
SUV420h2 in the retina and its capillary cells in hypergly-
cemia, and prevention of H4K20me3 at sod2 by its siRNA,
strongly suggest SUV420h2 is important in the metabolic
memory phenomenon associated with diabetic retinopa-
thy. We cannot, however, rule out the regulation of retinal
sod2 by other histone and nonhistone modiﬁcations, in-
cluding methylation of H3K9 and activation of Set7/9.
In conclusion, this is the ﬁrst report showing that retinal
sod2 is epigenetically regulated in diabetes and that these
modiﬁcations continue after termination of hyperglycemia,
suggesting their role in the metabolic memory phenome-
non associated with the continued progression of diabetic
retinopathy. Modulation of epigenetic changes by phar-
maceutical or molecular means may provide a potential
strategy to retard the development/progression of diabetic
retinopathy.
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